Socioeconomic and insurance status are independent prognostic indicators of higher disease stage and worse prognosis in bladder cancer-Reference-Cited by-同舟云学术

Socioeconomic and insurance status are independent prognostic indicators of higher disease stage and worse prognosis in bladder cancer

Published:2019-10 Issue:10 Volume:37 Page:784-790
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Nazemi Azadeh,Ghodoussipour Saum^ORCID,Pearce Shane,Bhanvadia Sumeet,Daneshmand Siamak^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference23 articles.

1. The impact of socioeconomic status on perioperative complications and oncologic outcomes in patients undergoing radical cystectomy;Golombos;World J Urol,2017

2. Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer;Klapheke;Urol Oncol Semin Orig Investig,2018

3. The past, present, and future of cancer incidence in the United States: 1975 through 2020;Weir;Cancer,2015

4. 30-day all-cause hospital readmission after cystectomy: no worse for rural Medicare residents;Sadowski;Urol Oncol Semin Orig Investig,2018

5. Origins of socio-economic inequalities in cancer survival: a review;Woods;Ann Oncol,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system;BJU International;2024-04-29

2. The relationship between income, health insurance, and employment status as prognostic indicators of bladder cancer: A survival analysis;Archivio Italiano di Urologia e Andrologia;2024-03-07

3. Relationship Between Availability of Urologists and Primary Care Providers and Stage of Diagnosis for Invasive Urinary Bladder Cancer;Urology Practice;2024-03

4. The “Medicare effect” on head and neck cancer diagnosis and survival;Head & Neck;2023-04-25

5. Epidemiology, Screening, and Prevention of Bladder Cancer;European Urology Oncology;2022-12